The Efficacy of Antidepressants in the Treatment of Late-Life Depression
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
This review addresses the question of whether there is evidence that antidepressants are more efficacious than placebo in the treatment of late-life depression and what is the rate of response that physician and patient can expect when antidepressant medication is prescribed in a typical clinical setting. To date, 5 placebo-controlled and 10 comparison trials have study designs of sufficient rigor to provide evidence of antidepressant efficacy and effectiveness in the treatment of late-life depression. The results suggest that antidepressant medications are more effective than placebo. However, placebo-controlled trials are not a simple comparison of only medication versus placebo. Rather, the amount of nonspecific psychosocial interventions included in these trials is considerable and often not systematically measured. Trial design also affects outcome: response and remission rates in comparison trials consistently are 20% to 30% higher than those reported in placebo-controlled trials. Clinical trials do not consistently assess the many moderators that are believed to affect treatment outcome in late-life depression, and therefore, comparisons across studies are problematic because of an inability to determine whether patient samples are truly comparable. For future clinical trials to have maximal relevance, study design should evolve to reflect as closely as possible a typical clinical setting especially with respect to frequency and duration of patient visits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Williams, Jr., Barrett, J., Oxman, T., Frank, E., Katon, W., Sullivan, M., Cornell, J., & Sengupta, A. (2000) · JAMA · doi:10.1001/jama.284.12.1519 · Cited by 460
Keller, M. B. (2003) · JAMA · doi:10.1001/jama.289.23.3152 · Cited by 388
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
Schatzberg, A. F., Kremer, C., Rodrigues, H. E., & Murphy, G. M. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200209000-00007 · Cited by 215
Self-citationA Double-Blind Comparison of Sertraline and Fluoxetine in Depressed Elderly Outpatients
Newhouse, P. A., Krishnan, K. R. R., Doraiswamy, P. M., Richter, E. M., Batzar, E. D., & Clary, C. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0804 · Cited by 163
Optimal Length of Antidepressant Trials in Late-Life Depression
Sackeim, H. A., Roose, S. P., & Burt, T. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000170683.25802.12 · Cited by 42 · cited 1×
“Included are studies suggesting that it is possible to predict nonresponse with a high degree of accuracy on the basis of limited symptom reduction after 4 or 6 weeks of treatment.(5,6) This notion, which continues to gain in popular acceptance in the field, helps minimize patient exposure to ineffective treatments.”
BackgroundSelf-citation
Research works printed but not linked: 15
- Nelson, 1999, Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease., Am J Psychiatry, 156, 1024, 10.1176/ajp.156.7.1024 · DOI
- Mulsant, 2001, A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients., Am J Geriatr Psychiatry, 9, 406, 10.1097/00019442-200111000-00009 · DOI
- Navarro, 2001, Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study., Acta Psychiatr Scand, 103, 435, 10.1034/j.1600-0447.2001.00228.x · DOI
- Schweizer, 1990, What constitutes an adequate antidepressant trial for fluoxetine?, J Clin Psychiatry, 51, 8
- Wilson, 2001, Antidepressants versus placebo for the depressed elderly., Cochrane Database Syst Rev, 2, CD000561
- Schatzberg, 2000, Antidepressant early response and remission of venlafaxine and fluoxetine in geriatric outpatients., Eur Neuropsychopharmacol, 10, S225, 10.1016/S0924-977X(00)80151-0 · doi:10.1016/s0924-977x(00)80151-0
- Rapaport, 2003, Efficacy of controlled-release paroxetine in the treatment of late-life depression., J Clin Psychiatry, 64, 1065, 10.4088/JCP.v64n0912 · DOI
- Roose, 2004, Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial., Am J Psychiatry, 161, 2050, 10.1176/appi.ajp.161.11.2050 · DOI · Paper page
- Bondareff, 2000, Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life., Am J Psychiatry, 157, 729, 10.1176/appi.ajp.157.5.729 · DOI · Paper page
- Tollefson, 1995, A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group., Int Psychogeriatr, 7, 89, 10.1017/S1041610295001888 · DOI · Paper page
- Schatzberg, 2000, Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression., Biol Psychiatry, 47, 736, 10.1016/S0006-3223(00)00846-5 · DOI
- Fawcett, 1987, Clinical management-imipramine/placebo administration manual. NIMH Treatment of Depression Collaborative Research Program., Psychopharmacol Bull, 23, 309
- Schneider, 2003, An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression., Am J Psychiatry, 160, 1277, 10.1176/appi.ajp.160.7.1277 · DOI · Paper page
- Mamdani, 2000, Use of antidepressants among elderly subjects: trends and contributing factors., Am J Psychiatry, 157, 360, 10.1176/appi.ajp.157.3.360 · DOI
- Katona, 2002, How well do antidepressants work in older people? A systematic review of number needed to treat., J Affect Disord, 69, 47, 10.1016/S0165-0327(00)00332-3 · DOI
Cited by
Slavich, G. M., & Irwin, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0035302 · Cited by 2,206
“…and only about 30%–35% of adults achieve remission using current therapeutic approaches, leaving over two thirds of the disease burden intact (Alexopoulos, 2005; Andrews, Issakidis, Sanderson, Corry, & Lapsley, 2004; Chisholm, Sanderson, Ayuso-Mateos, & Saxena, 2004; Roose & Schatzberg, 2005).”
BackgroundNaismith, S. L., Norrie, L. M., Mowszowski, L., & Hickie, I. B. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.05.009 · Cited by 270
Nelson, J. C., Delucchi, K., & Schneider, L. S. (2008) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000308883.64832.ed · Cited by 230
Treatment of Vascular Depression Using Repetitive Transcranial Magnetic Stimulation
Jorge, R. E., Moser, D. J., Acion, L., & Robinson, R. G. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.45 · Cited by 211
Irwin, M. R., Carrillo, C., Sadeghi, N., Bjurstrom, M. F., Breen, E. C., & Olmstead, R. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.3422 · Cited by 203
Metadata
- Authors
- Roose, S. P., & Schatzberg, A. F.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2005-08
- Volume
- 25
- Issue
- 4
- Pages
- S1-S7
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2046456855
- Cited by
- 154
- References
- 5
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Efficacy of Antidepressants in the Treatment of Late-Life Depression. https://app.cochat.ai/papers/10.1097/01.jcp.0000162807.84570.6b
- The paper
- Roose, S. P., & Schatzberg, A. F. (2005). The Efficacy of Antidepressants in the Treatment of Late-Life Depression. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/01.jcp.0000162807.84570.6b
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.